Full Press Release Details
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences:
2026 RBC Capital Markets Global Healthcare ConferenceFormat: Fireside chat and one-on-one investor meetingsParticipants: Roop K. Lakkaraju, Chief Financial OfficerDate and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a livewebcastand subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website atbio-rad.com
Jefferies 2026 Global Healthcare ConferenceFormat: Fireside chat and one-on-one investor meetingsParticipants: Roop K. Lakkaraju, Chief Financial OfficerDate and Time: Wednesday, June 3, 2026 at 8:45 AM Eastern Time; a livewebcastand subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website atbio-rad.com
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with over 7,400 employees, and $2.6 billion in revenues in 2025. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visitbio-rad.com.